Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2526 entries
Sorted by: Best Match Show Resources per page
Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells.

Stem cells international

Mathiasen AB, Hansen L, Friis T, Thomsen C, Bhakoo K, Kastrup J.
PMID: 23577035
Stem Cells Int. 2013;2013:353105. doi: 10.1155/2013/353105. Epub 2013 Mar 19.

Background. Regenerative therapy is an emerging treatment modality. To determine migration and retention of implanted cells, it is crucial to develop noninvasive tracking methods. The aim was to determine ex vivo magnetic resonance imaging (MRI) detection limits of ultrasmall...

Cite
Mathiasen AB, Hansen L, Friis T, et al. Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells. Stem Cells Int. 2013;2013:353105doi: 10.1155/2013/353105.
Mathiasen, A. B., Hansen, L., Friis, T., Thomsen, C., Bhakoo, K., & Kastrup, J. (2013). Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells. Stem cells international, 2013353105. https://doi.org/10.1155/2013/353105
Mathiasen, Anders Bruun, et al. "Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells." Stem cells international vol. 2013 (2013): 353105. doi: https://doi.org/10.1155/2013/353105
Mathiasen AB, Hansen L, Friis T, Thomsen C, Bhakoo K, Kastrup J. Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells. Stem Cells Int. 2013;2013:353105. doi: 10.1155/2013/353105. Epub 2013 Mar 19. PMID: 23577035; PMCID: PMC3614076.
Copy Download .nbib Format: NLM
Embryonic stem cell-derived cardiomyocyte heterogeneity and the isolation of immature and committed cells for cardiac remodeling and regeneration.

Stem cells international

Boheler KR, Joodi RN, Qiao H, Juhasz O, Urick AL, Chuppa SL, Gundry RL, Wersto RP, Zhou R.
PMID: 21912557
Stem Cells Int. 2011;2011:214203. doi: 10.4061/2011/214203. Epub 2011 Sep 06.

Pluripotent stem cells represent one promising source for cell replacement therapy in heart, but differentiating embryonic stem cell-derived cardiomyocytes (ESC-CMs) are highly heterogeneous and show a variety of maturation states. In this study, we employed an ESC clonal line...

Cite
Boheler KR, Joodi RN, Qiao H, et al. Embryonic stem cell-derived cardiomyocyte heterogeneity and the isolation of immature and committed cells for cardiac remodeling and regeneration. Stem Cells Int. 2011;2011:214203doi: 10.4061/2011/214203.
Boheler, K. R., Joodi, R. N., Qiao, H., Juhasz, O., Urick, A. L., Chuppa, S. L., Gundry, R. L., Wersto, R. P., & Zhou, R. (2011). Embryonic stem cell-derived cardiomyocyte heterogeneity and the isolation of immature and committed cells for cardiac remodeling and regeneration. Stem cells international, 2011214203. https://doi.org/10.4061/2011/214203
Boheler, Kenneth R, et al. "Embryonic stem cell-derived cardiomyocyte heterogeneity and the isolation of immature and committed cells for cardiac remodeling and regeneration." Stem cells international vol. 2011 (2011): 214203. doi: https://doi.org/10.4061/2011/214203
Boheler KR, Joodi RN, Qiao H, Juhasz O, Urick AL, Chuppa SL, Gundry RL, Wersto RP, Zhou R. Embryonic stem cell-derived cardiomyocyte heterogeneity and the isolation of immature and committed cells for cardiac remodeling and regeneration. Stem Cells Int. 2011;2011:214203. doi: 10.4061/2011/214203. Epub 2011 Sep 06. PMID: 21912557; PMCID: PMC3168772.
Copy Download .nbib Format: NLM
Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies.

Stem cells international

Abarrategi A, Tornin J, Martinez-Cruzado L, Hamilton A, Martinez-Campos E, Rodrigo JP, González MV, Baldini N, Garcia-Castro J, Rodriguez R.
PMID: 27366153
Stem Cells Int. 2016;2016:3631764. doi: 10.1155/2016/3631764. Epub 2016 Jun 05.

Osteosarcoma (OS) is the most common type of primary solid tumor that develops in bone. Although standard chemotherapy has significantly improved long-term survival over the past few decades, the outcome for those patients with metastatic or recurrent OS remains...

Cite
Abarrategi A, Tornin J, Martinez-Cruzado L, et al. Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies. Stem Cells Int. 2016;2016:3631764doi: 10.1155/2016/3631764.
Abarrategi, A., Tornin, J., Martinez-Cruzado, L., Hamilton, A., Martinez-Campos, E., Rodrigo, J. P., González, M. V., Baldini, N., Garcia-Castro, J., & Rodriguez, R. (2016). Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies. Stem cells international, 20163631764. https://doi.org/10.1155/2016/3631764
Abarrategi, Ander, et al. "Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies." Stem cells international vol. 2016 (2016): 3631764. doi: https://doi.org/10.1155/2016/3631764
Abarrategi A, Tornin J, Martinez-Cruzado L, Hamilton A, Martinez-Campos E, Rodrigo JP, González MV, Baldini N, Garcia-Castro J, Rodriguez R. Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies. Stem Cells Int. 2016;2016:3631764. doi: 10.1155/2016/3631764. Epub 2016 Jun 05. PMID: 27366153; PMCID: PMC4913005.
Copy Download .nbib Format: NLM
Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials.

Stem cells international

Moniche F, Rosado-de-Castro PH, Escudero I, Zapata E, de la Torre Laviana FJ, Mendez-Otero R, Carmona M, Piñero P, Bustamante A, Lebrato L, Cabezas JA, Gonzalez A, de Freitas GR, Montaner J.
PMID: 27525011
Stem Cells Int. 2016;2016:8657173. doi: 10.1155/2016/8657173. Epub 2016 Jul 21.

Background and Purpose. BM-MNC transplantation improves recovery in experimental models of ischemic stroke. Clinical trials are ongoing to test efficacy in stroke patients. However, whether cell dose is related to outcomes is not known. Methods. We performed a pooling...

Cite
Moniche F, Rosado-de-Castro PH, Escudero I, et al. Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials. Stem Cells Int. 2016;2016:8657173doi: 10.1155/2016/8657173.
Moniche, F., Rosado-de-Castro, P. H., Escudero, I., Zapata, E., de la Torre Laviana, F. J., Mendez-Otero, R., Carmona, M., Piñero, P., Bustamante, A., Lebrato, L., Cabezas, J. A., Gonzalez, A., de Freitas, G. R., & Montaner, J. (2016). Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials. Stem cells international, 20168657173. https://doi.org/10.1155/2016/8657173
Moniche, Francisco, et al. "Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials." Stem cells international vol. 2016 (2016): 8657173. doi: https://doi.org/10.1155/2016/8657173
Moniche F, Rosado-de-Castro PH, Escudero I, Zapata E, de la Torre Laviana FJ, Mendez-Otero R, Carmona M, Piñero P, Bustamante A, Lebrato L, Cabezas JA, Gonzalez A, de Freitas GR, Montaner J. Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials. Stem Cells Int. 2016;2016:8657173. doi: 10.1155/2016/8657173. Epub 2016 Jul 21. PMID: 27525011; PMCID: PMC4972913.
Copy Download .nbib Format: NLM
Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment.

Stem cells international

Sutton MT, Fletcher D, Ghosh SK, Weinberg A, van Heeckeren R, Kaur S, Sadeghi Z, Hijaz A, Reese J, Lazarus HM, Lennon DP, Caplan AI, Bonfield TL.
PMID: 26925108
Stem Cells Int. 2016;2016:5303048. doi: 10.1155/2016/5303048. Epub 2016 Jan 26.

Cystic fibrosis (CF) is a genetic disease in which the battle between pulmonary infection and inflammation becomes the major cause of morbidity and mortality. We have previously shown that human MSCs (hMSCs) decrease inflammation and infection in the in...

Cite
Sutton MT, Fletcher D, Ghosh SK, et al. Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment. Stem Cells Int. 2016;2016:5303048doi: 10.1155/2016/5303048.
Sutton, M. T., Fletcher, D., Ghosh, S. K., Weinberg, A., van Heeckeren, R., Kaur, S., Sadeghi, Z., Hijaz, A., Reese, J., Lazarus, H. M., Lennon, D. P., Caplan, A. I., & Bonfield, T. L. (2016). Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment. Stem cells international, 20165303048. https://doi.org/10.1155/2016/5303048
Sutton, Morgan T, et al. "Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment." Stem cells international vol. 2016 (2016): 5303048. doi: https://doi.org/10.1155/2016/5303048
Sutton MT, Fletcher D, Ghosh SK, Weinberg A, van Heeckeren R, Kaur S, Sadeghi Z, Hijaz A, Reese J, Lazarus HM, Lennon DP, Caplan AI, Bonfield TL. Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment. Stem Cells Int. 2016;2016:5303048. doi: 10.1155/2016/5303048. Epub 2016 Jan 26. PMID: 26925108; PMCID: PMC4746399.
Copy Download .nbib Format: NLM
Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis.

Stem cells international

Simovic Markovic B, Nikolic A, Gazdic M, Nurkovic J, Djordjevic I, Arsenijevic N, Stojkovic M, Lukic ML, Volarevic V.
PMID: 27057168
Stem Cells Int. 2016;2016:2640746. doi: 10.1155/2016/2640746. Epub 2016 Jan 04.

Transplantation of mesenchymal stem cells (MSCs) reduces the severity of dextran sulphate sodium- (DSS-) induced colitis. MSCs are able to secrete Galectin-3 (Gal-3), a protein known to affect proliferation, adhesion, and migration of immune cells. We investigate whether newly...

Cite
Simovic Markovic B, Nikolic A, Gazdic M, et al. Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis. Stem Cells Int. 2016;2016:2640746doi: 10.1155/2016/2640746.
Simovic Markovic, B., Nikolic, A., Gazdic, M., Nurkovic, J., Djordjevic, I., Arsenijevic, N., Stojkovic, M., Lukic, M. L., & Volarevic, V. (2016). Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis. Stem cells international, 20162640746. https://doi.org/10.1155/2016/2640746
Simovic Markovic, Bojana, et al. "Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis." Stem cells international vol. 2016 (2016): 2640746. doi: https://doi.org/10.1155/2016/2640746
Simovic Markovic B, Nikolic A, Gazdic M, Nurkovic J, Djordjevic I, Arsenijevic N, Stojkovic M, Lukic ML, Volarevic V. Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis. Stem Cells Int. 2016;2016:2640746. doi: 10.1155/2016/2640746. Epub 2016 Jan 04. PMID: 27057168; PMCID: PMC4736319.
Copy Download .nbib Format: NLM
Differential Proteomic Analysis of Human Placenta-Derived Mesenchymal Stem Cells Cultured on Normal Tissue Culture Surface and Hyaluronan-Coated Surface.

Stem cells international

Wong TY, Chen YH, Liu SH, Solis MA, Yu CH, Chang CH, Huang LL.
PMID: 27057169
Stem Cells Int. 2016;2016:2809192. doi: 10.1155/2016/2809192. Epub 2015 Dec 29.

Our previous results showed that hyaluronan (HA) preserved human placenta-derived mesenchymal stem cells (PDMSC) in a slow cell cycling mode similar to quiescence, the pristine state of stem cells in vivo, and HA was found to prevent murine adipose-derived...

Cite
Wong TY, Chen YH, Liu SH, et al. Differential Proteomic Analysis of Human Placenta-Derived Mesenchymal Stem Cells Cultured on Normal Tissue Culture Surface and Hyaluronan-Coated Surface. Stem Cells Int. 2015;2016:2809192doi: 10.1155/2016/2809192.
Wong, T. Y., Chen, Y. H., Liu, S. H., Solis, M. A., Yu, C. H., Chang, C. H., & Huang, L. L. (2016). Differential Proteomic Analysis of Human Placenta-Derived Mesenchymal Stem Cells Cultured on Normal Tissue Culture Surface and Hyaluronan-Coated Surface. Stem cells international, 20162809192. https://doi.org/10.1155/2016/2809192
Wong, Tzyy Yue, et al. "Differential Proteomic Analysis of Human Placenta-Derived Mesenchymal Stem Cells Cultured on Normal Tissue Culture Surface and Hyaluronan-Coated Surface." Stem cells international vol. 2016 (2016): 2809192. doi: https://doi.org/10.1155/2016/2809192
Wong TY, Chen YH, Liu SH, Solis MA, Yu CH, Chang CH, Huang LL. Differential Proteomic Analysis of Human Placenta-Derived Mesenchymal Stem Cells Cultured on Normal Tissue Culture Surface and Hyaluronan-Coated Surface. Stem Cells Int. 2016;2016:2809192. doi: 10.1155/2016/2809192. Epub 2015 Dec 29. PMID: 27057169; PMCID: PMC4709773.
Copy Download .nbib Format: NLM
Lipogems Product Treatment Increases the Proliferation Rate of Human Tendon Stem Cells without Affecting Their Stemness and Differentiation Capability.

Stem cells international

Randelli P, Menon A, Ragone V, Creo P, Bergante S, Randelli F, De Girolamo L, Alfieri Montrasio U, Banfi G, Cabitza P, Tettamanti G, Anastasia L.
PMID: 27057170
Stem Cells Int. 2016;2016:4373410. doi: 10.1155/2016/4373410. Epub 2016 Jan 06.

Increasing the success rate of rotator cuff healing remains tremendous challenge. Among many approaches, the possibility of activating resident stem cells in situ, without the need to isolate them from biopsies, could represent valuable therapeutic strategy. Along this line,...

Cite
Randelli P, Menon A, Ragone V, et al. Lipogems Product Treatment Increases the Proliferation Rate of Human Tendon Stem Cells without Affecting Their Stemness and Differentiation Capability. Stem Cells Int. 2016;2016:4373410doi: 10.1155/2016/4373410.
Randelli, P., Menon, A., Ragone, V., Creo, P., Bergante, S., Randelli, F., De Girolamo, L., Alfieri Montrasio, U., Banfi, G., Cabitza, P., Tettamanti, G., & Anastasia, L. (2016). Lipogems Product Treatment Increases the Proliferation Rate of Human Tendon Stem Cells without Affecting Their Stemness and Differentiation Capability. Stem cells international, 20164373410. https://doi.org/10.1155/2016/4373410
Randelli, Pietro, et al. "Lipogems Product Treatment Increases the Proliferation Rate of Human Tendon Stem Cells without Affecting Their Stemness and Differentiation Capability." Stem cells international vol. 2016 (2016): 4373410. doi: https://doi.org/10.1155/2016/4373410
Randelli P, Menon A, Ragone V, Creo P, Bergante S, Randelli F, De Girolamo L, Alfieri Montrasio U, Banfi G, Cabitza P, Tettamanti G, Anastasia L. Lipogems Product Treatment Increases the Proliferation Rate of Human Tendon Stem Cells without Affecting Their Stemness and Differentiation Capability. Stem Cells Int. 2016;2016:4373410. doi: 10.1155/2016/4373410. Epub 2016 Jan 06. PMID: 27057170; PMCID: PMC4736573.
Copy Download .nbib Format: NLM
Lavandula angustifolia Extract Improves the Result of Human Umbilical Mesenchymal Wharton's Jelly Stem Cell Transplantation after Contusive Spinal Cord Injury in Wistar Rats.

Stem cells international

Yaghoobi K, Kaka G, Mansouri K, Davoodi S, Sadraie SH, Hosseini SR.
PMID: 27057171
Stem Cells Int. 2016;2016:5328689. doi: 10.1155/2016/5328689. Epub 2016 Feb 14.

Introduction. The primary trauma of spinal cord injury (SCI) results in severe damage to nervous functions. At the cellular level, SCI causes astrogliosis. Human umbilical mesenchymal stem cells (HUMSCs), isolated from Wharton's jelly of the umbilical cord, can be...

Cite
Yaghoobi K, Kaka G, Mansouri K, et al. Lavandula angustifolia Extract Improves the Result of Human Umbilical Mesenchymal Wharton's Jelly Stem Cell Transplantation after Contusive Spinal Cord Injury in Wistar Rats. Stem Cells Int. 2016;2016:5328689doi: 10.1155/2016/5328689.
Yaghoobi, K., Kaka, G., Mansouri, K., Davoodi, S., Sadraie, S. H., & Hosseini, S. R. (2016). Lavandula angustifolia Extract Improves the Result of Human Umbilical Mesenchymal Wharton's Jelly Stem Cell Transplantation after Contusive Spinal Cord Injury in Wistar Rats. Stem cells international, 20165328689. https://doi.org/10.1155/2016/5328689
Yaghoobi, Kayvan, et al. "Lavandula angustifolia Extract Improves the Result of Human Umbilical Mesenchymal Wharton's Jelly Stem Cell Transplantation after Contusive Spinal Cord Injury in Wistar Rats." Stem cells international vol. 2016 (2016): 5328689. doi: https://doi.org/10.1155/2016/5328689
Yaghoobi K, Kaka G, Mansouri K, Davoodi S, Sadraie SH, Hosseini SR. Lavandula angustifolia Extract Improves the Result of Human Umbilical Mesenchymal Wharton's Jelly Stem Cell Transplantation after Contusive Spinal Cord Injury in Wistar Rats. Stem Cells Int. 2016;2016:5328689. doi: 10.1155/2016/5328689. Epub 2016 Feb 14. PMID: 27057171; PMCID: PMC4769777.
Copy Download .nbib Format: NLM
Modulating the Substrate Stiffness to Manipulate Differentiation of Resident Liver Stem Cells and to Improve the Differentiation State of Hepatocytes.

Stem cells international

Cozzolino AM, Noce V, Battistelli C, Marchetti A, Grassi G, Cicchini C, Tripodi M, Amicone L.
PMID: 27057172
Stem Cells Int. 2016;2016:5481493. doi: 10.1155/2016/5481493. Epub 2016 Jan 12.

In many cell types, several cellular processes, such as differentiation of stem/precursor cells, maintenance of differentiated phenotype, motility, adhesion, growth, and survival, strictly depend on the stiffness of extracellular matrix that, in vivo, characterizes their correspondent organ and tissue....

Cite
Cozzolino AM, Noce V, Battistelli C, et al. Modulating the Substrate Stiffness to Manipulate Differentiation of Resident Liver Stem Cells and to Improve the Differentiation State of Hepatocytes. Stem Cells Int. 2016;2016:5481493doi: 10.1155/2016/5481493.
Cozzolino, A. M., Noce, V., Battistelli, C., Marchetti, A., Grassi, G., Cicchini, C., Tripodi, M., & Amicone, L. (2016). Modulating the Substrate Stiffness to Manipulate Differentiation of Resident Liver Stem Cells and to Improve the Differentiation State of Hepatocytes. Stem cells international, 20165481493. https://doi.org/10.1155/2016/5481493
Cozzolino, Angela Maria, et al. "Modulating the Substrate Stiffness to Manipulate Differentiation of Resident Liver Stem Cells and to Improve the Differentiation State of Hepatocytes." Stem cells international vol. 2016 (2016): 5481493. doi: https://doi.org/10.1155/2016/5481493
Cozzolino AM, Noce V, Battistelli C, Marchetti A, Grassi G, Cicchini C, Tripodi M, Amicone L. Modulating the Substrate Stiffness to Manipulate Differentiation of Resident Liver Stem Cells and to Improve the Differentiation State of Hepatocytes. Stem Cells Int. 2016;2016:5481493. doi: 10.1155/2016/5481493. Epub 2016 Jan 12. PMID: 27057172; PMCID: PMC4737459.
Copy Download .nbib Format: NLM
Mitochondrial DNA Hypomethylation Is a Biomarker Associated with Induced Senescence in Human Fetal Heart Mesenchymal Stem Cells.

Stem cells international

Yu D, Du Z, Pian L, Li T, Wen X, Li W, Kim SJ, Xiao J, Cohen P, Cui J, Hoffman AR, Hu JF.
PMID: 28484495
Stem Cells Int. 2017;2017:1764549. doi: 10.1155/2017/1764549. Epub 2017 Apr 06.

No abstract available.

Cite
Yu D, Du Z, Pian L, et al. Mitochondrial DNA Hypomethylation Is a Biomarker Associated with Induced Senescence in Human Fetal Heart Mesenchymal Stem Cells. Stem Cells Int. 2017;2017:1764549doi: 10.1155/2017/1764549.
Yu, D., Du, Z., Pian, L., Li, T., Wen, X., Li, W., Kim, S. J., Xiao, J., Cohen, P., Cui, J., Hoffman, A. R., & Hu, J. F. (2017). Mitochondrial DNA Hypomethylation Is a Biomarker Associated with Induced Senescence in Human Fetal Heart Mesenchymal Stem Cells. Stem cells international, 20171764549. https://doi.org/10.1155/2017/1764549
Yu, Dehai, et al. "Mitochondrial DNA Hypomethylation Is a Biomarker Associated with Induced Senescence in Human Fetal Heart Mesenchymal Stem Cells." Stem cells international vol. 2017 (2017): 1764549. doi: https://doi.org/10.1155/2017/1764549
Yu D, Du Z, Pian L, Li T, Wen X, Li W, Kim SJ, Xiao J, Cohen P, Cui J, Hoffman AR, Hu JF. Mitochondrial DNA Hypomethylation Is a Biomarker Associated with Induced Senescence in Human Fetal Heart Mesenchymal Stem Cells. Stem Cells Int. 2017;2017:1764549. doi: 10.1155/2017/1764549. Epub 2017 Apr 06. PMID: 28484495; PMCID: PMC5397648.
Copy Download .nbib Format: NLM
Mitochondrial Dynamics: In Cell Reprogramming as It Is in Cancer.

Stem cells international

Prieto J, Torres J.
PMID: 28484497
Stem Cells Int. 2017;2017:8073721. doi: 10.1155/2017/8073721. Epub 2017 Apr 17.

Somatic cells can be reprogrammed into a pluripotent cellular state similar to that of embryonic stem cells. Given the significant physiological differences between the somatic and pluripotent cells, cell reprogramming is associated with a profound reorganization of the somatic...

Cite
Prieto J, Torres J. Mitochondrial Dynamics: In Cell Reprogramming as It Is in Cancer. Stem Cells Int. 2017;2017:8073721doi: 10.1155/2017/8073721.
Prieto, J., & Torres, J. (2017). Mitochondrial Dynamics: In Cell Reprogramming as It Is in Cancer. Stem cells international, 20178073721. https://doi.org/10.1155/2017/8073721
Prieto, Javier, and Torres, Josema. "Mitochondrial Dynamics: In Cell Reprogramming as It Is in Cancer." Stem cells international vol. 2017 (2017): 8073721. doi: https://doi.org/10.1155/2017/8073721
Prieto J, Torres J. Mitochondrial Dynamics: In Cell Reprogramming as It Is in Cancer. Stem Cells Int. 2017;2017:8073721. doi: 10.1155/2017/8073721. Epub 2017 Apr 17. PMID: 28484497; PMCID: PMC5412136.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2526 entries